Analgesia Clinical Trial
Official title:
Pilot Randomized Controlled Trial on Music Use for Sedation In Critically Ill Children
Stress induced by pain and anxiety is common in pediatric intensive care unit (PICU) patients and can impede the delivery of care as well as their recovery. Sedation/analgesia in PICU is usually achieved using narcotics and benzodiazepines. Excessive use of these drugs can put patients at risk for hemodynamic and respiratory instability, prolonged mechanical ventilation, withdrawal symptoms, and delirium. Non-pharmacologic measures for analgesia and anxiolysis may reduce the total medication requirement and their side effects. The use of non-pharmacologic interventions, including music, has been recommended by sedation guidelines for critically ill patients; however, it is not clear how these interventions should be provided. We plan to conduct a pilot 3-arm RCT to determine the feasibility of a music intervention and assess its effects on sedation/analgesia requirements in children admitted to PICU. Children will be randomly assigned to receive music, noise cancellation or control. Music will be delivered by headphones and an iPod. Music will consist on classical music selected by the study's pediatric music therapist. The noise cancellation group will receive the same headphones but without music. Clinical care of the participants, including use of sedation and analgesia drugs, will not be protocolized. Primary outcomes of this pilot trial is feasibility. Secondary outcomes are drug requirements for sedation and analgesia, and incidence of delirium. These requirements will be captured as a daily intensity score and intermittent dose (PRN) frequency. Mixed-effects models will be used to analyze the effect of the music on sedation/analgesia requirements.
Aim and Objectives Overall Research Question Does music reduce sedation requirements in
critically ill children? Purpose statement We plan to conduct a pilot randomized controlled
trial (RCT) to determine the feasibility of a pediatric music medicine trial, and to study
the effects of music on sedation requirements in children admitted to the pediatric intensive
care unit (PICU).
Objectives: a) To demonstrate the feasibility of a music RCT in pediatric critical care; b)
To estimate the effect of music on the sedation requirements of critically ill children; c)
to obtain information about standard deviation and mean treatment effect for future sample
size calculation for a larger trial.
Hypothesis:
We hypothesize that: a) A RCT of music in critically ill children will be feasible; b) Music
will result in a 20 % reduction in sedation requirements.
Methodology Study design: We propose a pilot 3 arm RCT. Randomization will be done by a
computer-based program to ensure allocation concealment. A total of 30 patients will be
randomly assigned in a 1:1:1 ratio to receive music, noise cancellation or control.
Setting: Pediatric Intensive Care Units (Cardiac and General) at the Stollery Children's
Hospital, Edmonton, Alberta.
Study Population: critically ill children on mechanical ventilation and receiving sedation
and/or analgesia.
Intervention After consent and randomization, patients will be started on the assigned
intervention (music/noise cancellation/control) 24-48 hours after admission to the PICU.
Based on the neonatal and adult studies, in the music and noise cancellation groups the
intervention will be delivered during 30 minutes, at least 3 times a day. The control group
will receive usual care. Music will be delivered with the use of noise cancellation
headphones and an iPod touch (Apple, California). Music selection will be chosen based on the
patient's age. Classical music has been selected by a pediatric music therapist based on its
observed properties to settle and calm children. In the noise cancellation group the
intervention will be provided with the same headphones connected to an iPod with a silent
recording. Children will be assessed with the Sedation behavior scale (SBS) before and during
the intervention.29 Signs of agitation or an increase in the SBS will indicate failure of the
intervention. Patients will remain on protocol for a maximum of 7 days as long as they are on
invasive mechanical ventilation. A parent survey will be conducted at the end of the study.
This survey will be conducted on paper or electronically (REDCap, Research Electronic Data
Capture) as per the parents' preference.
Concomitant interventions: Clinical care will not be protocolized, and will be according to
usual care. Sedative administration will not be directed by the study protocol; it will be up
to the attending PICU physician. Assessment of the patients' sedation status and withdrawal
symptoms will be conducted every 6 hours by the bedside nurse. Sedation status will be
assessed with the use of the SBS while withdrawal will be assessed with the Withdrawal
Assessment Tool (WAT-1) score; both are well validated tools .29-32 Demographic variables: To
assess if the groups are comparable, including known risk factors, we will record the
following: demographic variables (sex, weight, age, diagnosis, operative status, Paediatric
Risk of Mortality (PRISM) score, inotrope score, Paediatric logistic organ dysfunction
(PELOD) score, baseline SBS, invasive procedures, presence of invasive lines and tubes).
Outcome variables: Feasibility, sedation requirements and delirium. Adverse events Adverse
events such as significant negative change in vital signs and/or any other sign of
intolerance (agitation) to the intervention will be recorded. We will also record any skin or
ear problems (pressure injuries) thought to be associated with the use of headphones.
Study procedures: Patients admitted to the Stollery Children's Hospital PICU and needing
mechanical ventilation will be screened for eligibility and approached for consent. After
consent, patient demographics will be recorded. Eligible patients will be randomly assigned
in a 1:1:1 ratio to the music, the noise cancellation or the control group. During
randomization we will stratify patients by age. As a patient qualifies for the trial, a study
number and a randomization number will be assigned. Based on the randomization code the
research nurse will proceed with one of the interventions, or control, as described above.
Masking: The research nurse will provide the iPods with music or silent recording based on
group allocation and will not disclose this information to the healthcare team or the family.
However, it is impossible to blind the use of headphones vs. control. The statistician
analyzing the data will be blinded to the group allocation.
Sample size justification: The primary outcome used to determine sample size for a future
larger RCT is daily Sedation Intensity Score (SIS). The minimal clinically important
difference determined by our survey is a reduction in sedation requirements of 20%.8 This
pilot study including 10 patients in each group (total 30 patients) will allow us to obtain
pediatric information to calculate a sample size for the larger trial.
Analysis Baseline characteristics will be analyzed by descriptive methods. Analysis will be
conducted on intention to treat basis and as per protocol. Mixed-effects models will be used
to analyze the primary effect of the music on sedation requirements. Statistical tests will
be 2-sided with 0.05 level of significance.
Data collection: Variables will be recorded in an anonymized database using REDCap, Research
Electronic Data Capture.34
Expected outcomes and Impact This pilot study is a necessary first step toward the conduct of
a larger music trial in critically ill children. To obtain funding from major agencies we
need to demonstrate the tolerability and feasibility of the intervention and patient
recruitment at our centre. This pilot study will also allow formal sample size calculation
for a larger trial and will allow us to obtain feedback from major stakeholders including
families.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05534230 -
Dexmedetomidine for Pain Reduction in CABG
|
N/A | |
Recruiting |
NCT06275698 -
HONEY for the Treatment of POst-Tonsillectomy Pain
|
N/A | |
Recruiting |
NCT04436224 -
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
|
Phase 4 | |
Not yet recruiting |
NCT04548323 -
Hypoalgesic Effects of Walking and Running Imagined
|
||
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT04394481 -
Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery
|
Phase 4 | |
Completed |
NCT04690647 -
The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.
|
N/A | |
Completed |
NCT05034601 -
ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure
|
N/A | |
Completed |
NCT03740815 -
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
|
N/A | |
Recruiting |
NCT05454202 -
Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
|
||
Recruiting |
NCT04554186 -
Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.
|
N/A | |
Suspended |
NCT04860635 -
Safety of F14 Following Total Knee Replacement
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06393777 -
Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion
|
N/A | |
Not yet recruiting |
NCT04519463 -
The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
|
Early Phase 1 | |
Completed |
NCT02916342 -
Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks
|
Phase 4 | |
Not yet recruiting |
NCT02549118 -
Tenoxicam for Intrapartum Analgesia
|
Phase 2 | |
Completed |
NCT03206554 -
Local Infiltration Analgesia in Total Knee Arthroplasty
|
Phase 2 | |
Not yet recruiting |
NCT02190760 -
Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block.
|
N/A | |
Completed |
NCT01789606 -
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
|
Phase 3 | |
Completed |
NCT01299584 -
ULTIVA Post Marketing Surveillance
|
N/A |